MDCorp (MDCX) Market Cap (2016 - 2026)
MDCorp (MDCX) market cap from Feb 3, 2016 to Jun 2, 2026. The current MDCorp (MDCX) market cap is $13M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
MDCorp (MDCX) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +51.03% |
| 10 Years TTM | +114.05% |
| All Time TTM | +101.79% |
Annual Market Cap change of MDCorp (MDCX)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $13M | -65.29% |
| 2025 | $39M | +34.15% |
| 2024 | $29M | +1395.72% |
| 2018 | $1.92M | +616.42% |
| 2017 | $268K | +346.67% |
| 2016 | $60K | N/A |
Comparison MDCorp (MDCX) market cap with competitors
MDCorp (MDCX) market cap is $13.37M.
| Ticker | Name | Market Cap | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | $969.83B | +7253450.75% |
| JNJ | Johnson & Johnson | $557.13B | +4166782.37% |
| ABBV | Abbvie Inc | $381.28B | +2851522.43% |
| MRK | Merck & Co Inc | $297.23B | +2222955.62% |
| AZN | Astrazeneca plc | $289.83B | +2167591.80% |
| NVS | Novartis AG | $289.55B | +2165460.62% |
| NVO | Novo Nordisk | $198.19B | +1482191.86% |
| AMGN | AMGEN Inc | $181.37B | +1356407.30% |
| GILD | Gilead Sciences Inc | $166.04B | +1241762.22% |
| PFE | Pfizer Inc | $149.16B | +1115499.99% |
| BMY | Bristol-Myers Squibb Company | $117.25B | +876802.78% |
| SNY | Sanofi | $107.01B | +800209.23% |
| GSK | GSK Plc | $105.07B | +785723.95% |
| BIIB | Biogen Inc | $28.99B | +216750.68% |
| GRFS | Grifols SA | $5.48B | +40875.57% |
| OGN | Organon & Company | $3.51B | +26183.59% |
| AMRN | Amarin Corp | $304.63M | +2178.34% |
| SCLX | Scilex Holding Company | $57.83M | +332.49% |
| MIRA | Mira Pharmaceuticals Inc | $48.54M | +263.00% |
| NSRX | Nasus Pharma Ltd | $27.23M | +103.63% |
| MDCXW | Medicus Pharma Ltd warrant | $14.00M | +4.70% |